findmyKOL
Clinical trialNCT06636175RecruitingEarly phase 1Interventional

64Cu-LLP2A for Imaging Hematologic Malignancies

SponsorWashington University School of MedicineEnrollment42Chronic Lymphocytic LeukemiaFollicular LymphomaLow-Grade LymphomaLymphoplasmacytic LymphomaMarginal Zone LymphomaMultiple Myeloma+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This phase of the protocol (protocol part B), seeks to evaluate the new formulation in healthy normal volunteers to confirm the new formulation provides comparable human dosimetry to which was seen and published in protocol part A. Additionally, the new formulation will be studied utilizing an expanded patient population to include patients with confirmed diagnosis of multiple myeloma (MM), low-grade lymphoma, or MM and lymphoma patients who are status post bone marrow transplant (BMT) with negative imaging and suspected recurrence.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Amanda Cashen, M.D.Armin Ghobadi, M.D.Farrokh Dehdashti, M.D.Fei Wan, Ph.D.Keith Stockerl-Goldstein, M.D.Mark A Schroeder, M.D.Ravi Vij, M.D.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

64Cu-LLP2A
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Mar 2025
Primary completion
31 Mar 2027
Completion
31 Mar 2027
Last update posted
17 Jun 2026
Registered enrollment
42
Registry id
NCT06636175
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.